Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01581281 · ClinicalTrials.gov registry record · Phase 3
The Childhood and Adolescent Migraine Prevention Study
A Phase 3 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Terminated
- Registry status
- Phase 3
- Development phase
- 488
- Enrollment target
NCT01581281 is a Phase 3 study that was terminated before completion, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 488 participants.
The verdict
NCT01581281, a Phase 3 study, was terminated before completion, sponsored by Children's Hospital Medical Center, Cincinnati.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 488 participants
- Enrollment target
Study Summary
The purpose of this research study is to test two medicines for migraine prevention in children and adolescents.
Interventions
- DRUG Placebo
- DRUG Amitriptyline
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 488 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01581281
The ClinicalTrials.gov registry entry for NCT01581281 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 488 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01581281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01581281 about?
NCT01581281 is a clinical study titled "The Childhood and Adolescent Migraine Prevention Study". The purpose of this research study is to test two medicines for migraine prevention in children and adolescents.
What is the current status of trial NCT01581281?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 488 participants. The study started on 2012-06. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01581281?
The interventions under investigation include: Placebo (DRUG), Amitriptyline (DRUG), Topiramate (DRUG).
Who is sponsoring clinical trial NCT01581281?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.